Back
Perspective Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
CATX
Perspective Therapeutics
Last Price:
$2.87
Seasonality Move:
41.25%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.Perspective Therapeutics Stock Forecast
-
Is Perspective Therapeutics Stock Undervalued?The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
Data Unavailable
Perspective Therapeutics Stock Rating
Data Unavailable
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
19.05
52-Week Low:
2.70
Prediction Charts
Market Cap:
192.6M
Price in USD:
2.85
Volume:
2.9M
Beta:
1.26
Technical Analysis
SMA50:
7.97
SMA100:
10.87
SMA200:
12.20
52-Wk Change:
-16.67%
Stock Predictions
-
Is Perspective Therapeutics stock public?Yes, Perspective Therapeutics is a publicly traded company.
-
What is the Perspective Therapeutics stock quote today?The Perspective Therapeutics stock price is 2.85 USD today.
-
How to buy Perspective Therapeutics stock online?You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 4.17 | 4.00 | 4.20 | 3.93 |
| Dec-4 | 4.01 | 3.71 | 4.03 | 3.66 |
| Dec-5 | 3.81 | 3.72 | 3.99 | 3.66 |
| Dec-6 | 3.74 | 3.76 | 3.85 | 3.53 |
| Dec-9 | 4.13 | 3.77 | 4.13 | 3.72 |
| Dec-10 | 3.75 | 3.65 | 3.83 | 3.53 |
| Dec-11 | 3.68 | 3.45 | 3.74 | 3.42 |
| Dec-12 | 3.42 | 3.47 | 3.56 | 3.31 |
| Dec-13 | 3.48 | 3.48 | 3.59 | 3.27 |
| Dec-16 | 3.47 | 3.48 | 3.60 | 3.40 |
| Dec-17 | 3.46 | 3.07 | 3.47 | 3.07 |
| Dec-18 | 3.10 | 2.97 | 3.29 | 2.95 |
| Dec-19 | 3.01 | 2.84 | 3.04 | 2.70 |
| Dec-20 | 2.83 | 2.85 | 2.96 | 2.80 |
Perspective Therapeutics Earnings
Data Unavailable
Perspective Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.